Journals / Türk Kardiyoloji Derneği Arşivi
Türk Kardiyoloji Derneği ArşiviFen
2017 · Cilt: 45 - Sayı: Suppl. 4
| Article | Author | Pages |
|---|---|---|
| EINSTEIN CHOICE: Comparison of rivaroxaban treatment and prophylactic doses with aspirin in the extended treatment of patients with venous thromboembolism | Cihangir KAYMAZ | 1–7 |
| After the GEMINI-ACS-1 trial | Mehmet Birhan YILMAZ | 8–9 |
| PIONEER AF-PCI trial | Murat ÖZDEMİR | 10–14 |
| Pericardioversion and catheter ablation use of rivaroxaban in light of X-VERT and VENTURE-AF trials | Rabia AKILLI, Mesut DEMİR | 15–23 |
| Importance of adherence and persistence in anticoagulant treatment:Advantages of once daily dosing | Erdem DİKER | 24–25 |
| How should one read “real-life data” regarding NOAC’s? “The case with rivaroxaban” | Özgür ASLAN | 26–32 |